XML 32 R23.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF ERRORS RESULTED IN MISSTATEMENTS (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Dec. 31, 2020
Jun. 30, 2020
Dec. 31, 2019
Equity awards liability $ 782,834   $ 782,834        
Liability for shares withheld 1,244,458   1,244,458        
Total current liabilities 6,076,917   6,076,917     2,120,371    
Total liabilities 6,086,654   6,086,654     2,129,033    
Common stock (dollars) 18,644   18,644     18,410    
Additional paid-in capital 145,657,327   145,657,327     141,612,140    
Accumulated deficit (125,905,431)   (125,905,431)     (119,419,109)    
Total stockholders’ equity $ 19,770,540 $ 20,793,668 $ 19,770,540 $ 20,793,668 $ 20,157,663 $ 22,211,441 $ 22,064,442 $ 11,749,513
Common stock (shares) 18,643,281   18,643,281     18,410,458    
Selling, general and administrative expenses $ 2,930,273 4,514,488 $ 11,688,208 7,384,379        
Total operating expenses 4,345,939 5,422,251 15,792,739 10,221,753        
Loss from operations (1,025,300) (3,016,975) (6,501,662) (3,761,839)        
Net loss $ (1,025,712) $ (3,009,982) $ (6,486,322) $ (3,743,653)        
Basic and Diluted $ (0.06) $ (0.16) $ (0.35) $ (0.22)        
Basic and Diluted 18,642,463 18,336,107 18,580,012 16,960,770        
Diluted 18,642,463 18,336,107 18,580,012 16,960,770        
Ending balance, value $ 19,770,540 $ 20,793,668 $ 19,770,540 $ 20,793,668        
Exercise of stock options, net of cashless exercise of 58,122 shares and 92,634 shares withheld   29,350 1,755,416 168,608        
Exercise of liability awards   3,042,394   3,042,394        
Equity compensation 712,068 3,139,551 6,006,443 3,329,303        
Supplemental disclosure of noncash investing and financing activities:                
Reclassification of stock option awards     1,411,108        
Common Stock [Member]                
Total stockholders’ equity 18,644 18,390 18,644 18,390 18,636 $ 18,410 18,028 16,042
Net loss        
Balance, shares 18,643,281 18,390,229 18,643,281 18,390,229        
Ending balance, value $ 18,644 $ 18,390 $ 18,644 $ 18,390        
Exercise of stock options, net of cashless exercise of 58,122 shares and 92,634 shares withheld   527 207 674        
Exercise of liability awards            
Additional Paid-in Capital [Member]                
Total stockholders’ equity 145,657,327 141,454,043 145,657,327 141,454,043 145,018,746 141,612,140 139,715,197 128,668,583
Net loss        
Ending balance, value 145,657,327 141,454,043 145,657,327 141,454,043        
Exercise of stock options, net of cashless exercise of 58,122 shares and 92,634 shares withheld   28,823 1,755,209 167,934        
Exercise of liability awards   3,042,394   3,042,394        
Retained Earnings [Member]                
Total stockholders’ equity (125,905,431) (120,678,765) (125,905,431) (120,678,765) $ (124,879,719) $ (119,419,109) $ (117,668,783) $ (116,935,112)
Net loss (1,025,712) (3,009,982) (6,486,322) (3,743,653)        
Ending balance, value (125,905,431) (120,678,765) (125,905,431) (120,678,765)        
Exercise of stock options, net of cashless exercise of 58,122 shares and 92,634 shares withheld          
Exercise of liability awards            
Previously Reported [Member]                
Equity awards liability            
Liability for shares withheld            
Total current liabilities 4,049,625   4,049,625          
Total liabilities 4,059,362   4,059,362          
Common stock (dollars) 18,736   18,736          
Additional paid-in capital 140,905,895   140,905,895          
Accumulated deficit (119,126,799)   (119,126,799)          
Total stockholders’ equity $ 21,797,832 20,793,668 $ 21,797,832 20,793,668        
Common stock (shares) 18,735,915   18,735,915          
Selling, general and administrative expenses $ 2,856,794 1,472,094 $ 7,951,970 4,341,985        
Total operating expenses 4,272,460 2,379,857 12,056,501 7,179,359        
Loss from operations (951,821) 25,419 (2,765,424) (719,445)        
Net loss $ (952,233) $ 32,412 $ (2,750,084) $ (701,259)        
Basic and Diluted $ (0.05) $ 0.00 $ (0.15) $ (0.04)        
Basic and Diluted 18,735,097 18,336,107 18,653,823 16,960,770        
Diluted   18,764,994            
Ending balance, value $ 21,797,832 $ 20,793,668 $ 21,797,832 $ 20,793,668        
Exercise of stock options, net of cashless exercise of 58,122 shares and 92,634 shares withheld     46,470          
Exercise of liability awards            
Equity compensation     2,270,205 286,909        
Supplemental disclosure of noncash investing and financing activities:                
Reclassification of stock option awards              
Previously Reported [Member] | Common Stock [Member]                
Total stockholders’ equity $ 18,736   $ 18,736          
Balance, shares 18,735,915   18,735,915          
Ending balance, value $ 18,736   $ 18,736          
Previously Reported [Member] | Additional Paid-in Capital [Member]                
Total stockholders’ equity 140,905,895 138,411,649 140,905,895 138,411,649        
Ending balance, value 140,905,895 138,411,649 140,905,895 138,411,649        
Previously Reported [Member] | Retained Earnings [Member]                
Total stockholders’ equity (119,126,799) (117,636,371) (119,126,799) (117,636,371)        
Ending balance, value (119,126,799) (117,636,371) (119,126,799) (117,636,371)        
Revision of Prior Period, Adjustment [Member]                
Equity awards liability 782,834   782,834          
Liability for shares withheld 1,244,458   1,244,458          
Total current liabilities 2,027,292   2,027,292          
Total liabilities 2,027,292   2,027,292          
Common stock (dollars) (92)   (92)          
Additional paid-in capital 4,751,432   4,751,432          
Accumulated deficit (6,778,632)   (6,778,632)          
Total stockholders’ equity $ (2,027,292) $ (2,027,292)        
Common stock (shares) (92,634)   (92,634)          
Selling, general and administrative expenses $ 73,479 3,042,394 $ 3,736,238 3,042,394        
Total operating expenses 73,479 3,042,394 3,736,238 3,042,394        
Loss from operations (73,479) (3,042,394) (3,736,238) (3,042,394)        
Net loss $ (73,479) $ (3,042,394) $ (3,736,238) $ (3,042,394)        
Basic and Diluted $ (0.01) $ (0.16) $ (0.20) $ (0.18)        
Basic and Diluted (92,634) (73,811)        
Diluted   (428,887)            
Ending balance, value $ (2,027,292) $ (2,027,292)        
Exercise of stock options, net of cashless exercise of 58,122 shares and 92,634 shares withheld     1,708,946          
Exercise of liability awards   3,042,394   3,042,394        
Equity compensation     3,736,238 3,042,394        
Supplemental disclosure of noncash investing and financing activities:                
Reclassification of stock option awards     1,411,108          
Revision of Prior Period, Adjustment [Member] | Common Stock [Member]                
Total stockholders’ equity $ (92)   $ (92)          
Balance, shares (92,634)   (92,634)          
Ending balance, value $ (92)   $ (92)          
Revision of Prior Period, Adjustment [Member] | Additional Paid-in Capital [Member]                
Total stockholders’ equity 4,751,432 3,042,394 4,751,432 3,042,394        
Ending balance, value 4,751,432 3,042,394 4,751,432 3,042,394        
Revision of Prior Period, Adjustment [Member] | Retained Earnings [Member]                
Total stockholders’ equity (6,778,632) (3,042,394) (6,778,632) (3,042,394)        
Ending balance, value $ (6,778,632) $ (3,042,394) $ (6,778,632) $ (3,042,394)